3Reichart PA, Van Wyk CW, Becker J, et al. Distribution of procollagen type Ⅲ, collagen type VI and tenascin in oral submucous fibrosis (OSF) [J]. J Oral Pathol Med, 1994, 23 (9) : 394-398. 被引量：1
4Kawaguchi Y, Suzukik K, Hara H,et al.Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis[J] .Ann Rheum Dis, 1994,53 (38) : 506-510. 被引量：1
5Haque MF, Harris M, Meghji S, et al. Immunolocalization of cytokines and growth factors in oral submucous fibrosis [J]. Cytokine,1998, 10(9) :713-719. 被引量：1
7Phatak AG.Oral submucous fibrosis a chronic dissemination in travascular coagulation syndrome with local coagulpathy [J]. Gut,1993, 34(5) :71-73. 被引量：1
8Zhang LP, Takahara T, Yata Y, et al. Increased expression of plasminogen activator and plasminogen activators inhibitor during during liver fibrogenesis of rats: role of stellate cells [J]. Journal of Hepatology 1999, 31 (4) : 703-711. 被引量：1
9Yang SF, Hsieh YS, Tsai CH, et al. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis [J].Oral Oncol, 2003,39 (4) : 367-372. 被引量：1
10C P Chiang, H Y Wu, B Y Liu, et al. Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan [J]. Oral Oncology, 2002,38 (1) : 56-63. 被引量：1
